Upsher-Smith Laboratories Enters Into Exclusive Marketing And Distribution Agreement With Emerging Pharmaceutical Company

MAPLE GROVE, Minn., Aug. 25, 2016 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith) announced that it has entered into an exclusive agreement with an emerging pharmaceutical company to market and distribute a generic central nervous system (CNS) product with U.S. sales of more than $200 million for the 12 months ending June 2016, according to IMS Health. This collaboration is part of Upsher-Smith's company-wide effort to grow its generics pipeline and to expand its strategic relationships within the pharmaceutical industry.

Upsher-Smith Laboratories, Inc.

Under the terms of the agreement, the partner will develop, manufacture and supply the product exclusively for Upsher-Smith, which will market and distribute the product under its own label in the United States. Financial terms related to the deal have not been disclosed.

"Upsher-Smith has long been recognized within the pharmaceutical industry as a trusted name in the generics marketplace," said Rusty Field, President, Upsher-Smith. "This new agreement demonstrates the company's commitment to expanding its portfolio of high-quality, high-value generic products for patients." 

About Upsher-Smith

Upsher-Smith Laboratories, Inc., founded in 1919, is a growing, fully integrated pharmaceutical company dedicated to its mission of delivering high-value, high-quality therapies and solutions which measurably improve individuals' lives.  As a family-owned pharmaceutical company, we are able to adapt and thrive in a dynamic healthcare environment. Our world is constantly evolving, and we are continually adapting to the ever-changing needs of patients, physicians, pharmacists, and healthcare organizations. Where there is a need, we will work to deliver solutions that simplify access to treatment, deliver better health outcomes, and enhance life. For more information, visit www.upsher-smith.com.

Logo - http://photos.prnewswire.com/prnh/20130520/NY17281LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/upsher-smith-enters-into-exclusive-marketing-and-distribution-agreement-with-emerging-pharmaceutical-company-300318334.html

SOURCE Upsher-Smith Laboratories, Inc.

Back to news